Catalent (CTLT) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1488061029

Biologics, Vaccines, Pharmaceuticals, Cosmetics, Supplements, Animal Health

Catalent Inc. is a global leader in developing and manufacturing innovative solutions for the pharmaceutical, biotechnology, and consumer health industries. The company operates through two main segments: Biologics and Pharma and Consumer Health.

The Biologics segment is focused on providing cutting-edge solutions for biologic proteins, cell and gene therapies, and vaccines. This includes formulation, development, and manufacturing services for parenteral dose forms, such as vials, prefilled syringes, and cartridges. Additionally, the company offers analytical development and testing services for large molecules, ensuring the highest quality and efficacy of its products.

The Pharma and Consumer Health segment offers a wide range of services, including formulation, development, and manufacturing of soft capsules for various customer products, such as prescription drugs, over-the-counter medications, dietary supplements, and animal health medicinal preparations. The company also provides clinical supply services, including manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials.

Catalent Inc. also offers specialized services, such as FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions, fill and finish operations for injectable products, and integrated development and product supply chain solutions. This enables the company to provide a comprehensive range of services to its clients, from development to commercialization.

The company serves a diverse range of clients, including pharmaceutical, biotechnology, and consumer health companies, as well as companies in other healthcare market segments, such as animal health and medical devices, and cosmetics industries. With a rich history dating back to 1933, Catalent Inc. is headquartered in Somerset, New Jersey, and has established itself as a trusted partner for companies seeking to develop and manufacture innovative healthcare products.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Catalent (CTLT) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Catalent (CTLT) - Stock Price & Dividends

CTLT Stock Overview

Market Cap in USD 10,214m
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 2014-07-31

CTLT Stock Ratings

Growth 5y 0.88
Fundamental -42.6
Dividend -
Rel. Performance vs Sector 3.43
Analysts 3.27/5
Fair Price Momentum 52.04 USD
Fair Price DCF -

CTLT Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

CTLT Growth Ratios

Growth 12m 46.63%
Growth Correlation 12m 43%
Growth Correlation 3m -54%
CAGR 5y 3.55%
CAGR/Mean DD 5y 0.12
Sharpe Ratio 12m 1.05
Alpha vs SP500 12m 12.40
Beta vs SP500 5y weekly 1.25
ValueRay RSI 17.49
Volatility GJR Garch 1y 16.34%
Price / SMA 50 -2.08%
Price / SMA 200 12.87%
Current Volume 921.8k
Average Volume 20d 1612.7k

External Links for CTLT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of CTLT stocks?
As of May 21, 2024, the stock is trading at USD 55.00 with a total of 921,831 shares traded.
Over the past week, the price has changed by -1.43%, over one month by -0.87%, over three months by -5.14% and over the past year by +47.97%.
What are the forecast for CTLT stock price target?
According to ValueRays Forecast Model, CTLT Catalent will be worth about 57.1 in May 2025. The stock is currently trading at 55.00. This means that the stock has a potential upside of +3.87%.
Issuer Forecast Upside
Wallstreet Target Price 56.7 3.09
Analysts Target Price 50.9 -7.40
ValueRay Target Price 57.1 3.87